NEW YORK (GenomeWeb) – Proteome Sciences said today it has conditionally raised £2.5 million ($3.9 million) through the placement of nearly 13.9 new ordinary shares of the company's stock. 

The shares were priced at 18 pence. Proteome Sciences will apply to place the shares for trading on the London Stock Exchanges' AIM on or around July 2, the company said. 

Proteome Sciences Executive Chairman Christopher Pearce has subscribed to about 1.8 million shares in the placement, while Vulpes Investment Management Private has subscribed to nearly 2.6 million shares. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.

Oct
10
Sponsored by
PerkinElmer

This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.